OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

查看原文 / View Original 编辑 / Edit

In Brief Posted: 1:35 PM PDT · October 20, 2026 Image Credits:FotografiaBasica (opens in a new window) / Getty Images Julie Bort OpenAI acquires startup Orchestra Bio⁠ to beef up its biotech business

简讯发布时间：2026年10月20日太平洋夏令时间下午1:35 图片来源：FotografiaBasica（在新窗口中打开）/ Getty Images Julie Bort OpenAI收购初创公司Orchestra Bio以加强其生物技术业务

OpenAI on Tuesday acquired a four-year-old AI biotech software startup called Orchestra Bio, the company announced via its website. Terms of the deal were not disclosed, but the startup had reportedly raised around $20 million as of 2025 from backers like Andreessen Horowitz, Atria, and 8VC.

OpenAI周二通过其网站宣布，已收购了一家名为Orchestra Bio的四年制AI生物技术软件初创公司。交易条款未披露，但据报道，截至2025年，该初创公司已从Andreessen Horowitz、Atria和8VC等支持者处筹集了约2000万美元。

Orchestra creates AI agents that help biotech companies manage the minutiae of drug discovery operations, from tracking finances to resolving scheduling issues with clinical trials. OpenAI says it’s adding Orchestra’s team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, a harness that aims to help researchers plan experiments and analyze results.

Orchestra创建的AI智能体可帮助生物技术公司管理药物研发运营中的琐事，从财务跟踪到解决临床试验的日程安排问题。OpenAI表示，它正在将Orchestra的团队和技术整合到其用于生命科学研究的AI模型Rosalind及其相关的Rosalind Workbench工具中，该工具旨在帮助研究人员规划实验并分析结果。

OpenAI has already won some big names as customers for Rosalind, including, it says, Moderna⁠ and Novo Nordisk⁠. The acquisition is a classic example of how the biggest AI labs (namely OpenAI and Anthropic) are building ever more software for the biggest industries, like pharma.

OpenAI已经赢得了包括Moderna和诺和诺德（Novo Nordisk）在内的一些知名客户使用Rosalind。此次收购是大型AI实验室（即OpenAI和Anthropic）如何为制药等大型行业构建更多软件的典型案例。

In the startup world, there is an ongoing fear that at any moment, the labs will launch new features and become competitors. In this case, Orchestra is getting absorbed, rather than stomped out.

在初创企业界，人们一直担心这些实验室随时会推出新功能并成为竞争对手。在这种情况下，Orchestra是被吸收了，而不是被挤垮。